Antioxidant status in newborns and infants suffering from congenital heart defects

Władysław Rokicki1, Adam Strzałkowski, Barbara Kłapcińska

  • 1Department of Pediatric Cardiology Medical University of Silesia, Katowice.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|February 19, 2004
PubMed

Insights

Infants with congenital heart defects (CHD) show an antioxidant imbalance, with lower vitamin E and altered glutathione peroxidase activity. Oxidative stress is linked to CHD in infants, highlighting potential therapeutic targets.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Cardiology

Background:

  • Free radicals are implicated in tissue damage, but their role in infant congenital heart defects (CHD) is understudied.
  • Congenital heart defects (CHD) affect newborns and infants, necessitating research into associated pathophysiological mechanisms.

Purpose of the Study:

  • To evaluate the antioxidant status in newborns and infants with CHD.
  • To investigate the relationship between oxidative stress markers and CHD in infants.

Main Methods:

  • Assessed antioxidant enzyme activities (superoxide dismutase, catalase, glutathione peroxidase) in blood.
  • Measured levels of low molecular weight antioxidants (vitamin E, uric acid, selenium) and malondialdehyde (MDA) as a lipid peroxidation marker.
  • Compared 23 infants with CHD (14 acyanotic, 9 cyanotic) against 18 healthy controls.

Main Results:

  • All infants, including controls, had low blood selenium.
  • Infants with CHD exhibited lower plasma vitamin E, significantly so in acyanotic cases.
  • Glutathione peroxidase activity was lowest in cyanotic infants, correlating with highest MDA levels (lipid peroxidation).
  • Uric acid levels were higher in cyanotic infants, potentially offering protection against oxidative damage.

Conclusions:

  • Enhanced oxidative stress, resulting from an imbalance between prooxidant and antioxidant reactions, is associated with congenital heart defect pathology in infants.
  • Specific antioxidant deficiencies (e.g., vitamin E) and altered enzyme activities (e.g., glutathione peroxidase) are observed in infants with CHD.

Related Concept Videos